Hyperprolactinemia: pathophysiology and therapeutic approach

@article{Capozzi2015HyperprolactinemiaPA,
  title={Hyperprolactinemia: pathophysiology and therapeutic approach},
  author={Anna Capozzi and Giovanni Scambia and Alfredo Pontecorvi and Stefano Lello},
  journal={Gynecological Endocrinology},
  year={2015},
  volume={31},
  pages={506 - 510}
}
Abstract Prolactin (PRL) is a hormone, mainly secreted by lactotroph cells of the anterior pituitary gland. Recent studies have shown it may also be produced by many extrapituitary cells. Its well-recognized PRL plays an important role in lactation during pregnancy, but it is involved in other biological functions such as angiogenesis, immunoregulation and osmoregulation. Hyperprolactinemia is a typical condition producing reproductive dysfunction in both sexes, resulting in hypogonadism… 
Hyperprolactinemia: Effect on Reproduction, Diagnosis, and Management
TLDR
The reproductive effects of hyperprolactinemia are reviewed, which may result in symptoms including menstrual disturbances, galactorrhea, neurologic symptoms, hypogonadism, infertility, and osteopenia.
Hyperprolactinaemia
TLDR
An update on the diagnostic and management approaches for the patient with hyperprolactinaemia and on the current data looking at the impact of high prolactin on metabolism, cardiovascular and immune systems is provided.
Antipsychotics and Hyperprolactinemia : Prevalence and Risk Factors
Hyperprolactinemia, a largely underestimated frequent endocrine disorder, may be due to various causes including different treatments. Antipsychotics, particularly, play a major role in its
Therapeutic effects of Schisandra chinensis on the hyperprolactinemia in rat.
TLDR
Results show that S. chinensis and its single compound, gomisin N, are regulators of PRL production and may be candidates for treatment of hyperprolactinemia and prolactinoma.
PROLACTIN AND HYPERPROLACTINAEMIA IN FEMALE REPRODUCTIVE ENDOCRINOLOGY – AN UPDATE
TLDR
Current knowledge on prolactin physiology, etiopathogenesis, clinical features, assessment, differential diagnosis, and teatment of hyperprolactinaemia in the female patient are reviewed.
Pituitary apoplexy of a giant prolactinoma during pregnancy
  • S. Khaldi, G. Saad, +7 authors K. Ach
  • Medicine
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2021
TLDR
This case report illustrates the efficacy of cytoreductive surgery in case of insufficient response to dopamine agonists to restore gonadal function and the possibility of a pregnancy should be considered in women with giant prolactinoma.
Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia
TLDR
The cannulated prolactin test was useful in excluding true hyperprolactinemia in 28.6% of patients with previously confirmed mildly elevated random prolactIn on two occasions, thus avoiding over-diagnosis and unnecessary imaging.
ASSOCIATION BETWEEN HYPERPROLACTINAEMIA AND OTHER CAUSES OF FEMALE INFERTILITY
TLDR
If adequate suppression of serum prolactin levels is achieved, but the pregnancy is still missing despite the fact that ovulatory cycles are established, the other causes of infertility should be searched for, and the clinician should not reject the possible existence of some unknown cause of infertility.
Polycystic ovarian syndrome and pituitary macroadenoma a deadly combination with good outcome
TLDR
In spite of having both Polycystic Ovarian Syndrome (PCOS) & Pituitary Macroadenoma, which warrant surgical management (major causes of Infertility) selected cases like the authors' can be managed medically successfully.
Kratom, an Emerging Drug of Abuse, Raises Prolactin and Causes Secondary Hypogonadism: Case Report
TLDR
This is the first report of hyperprolactinemia as the result of ingestion of kratom, a drug derived from the leaves of the tree Mitragyna speciose, which is native to southern Thailand.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Hyperprolactinemia: pathophysiology and management.
TLDR
Evidence to date suggests that cabergoline and quinagolide appear to have a good safety profile for women who wish to conceive, but hard evidence proving that dopamine agonists do not provoke congenital malformations when taken during early pregnancy is currently only available for bromocriptine.
Current treatment issues in female hyperprolactinaemia.
  • P. Crosignani
  • Medicine
    European journal of obstetrics, gynecology, and reproductive biology
  • 2006
TLDR
For patients with hyperprolactinaemia, pregnancy is safe and can frequently be beneficial, inducing a decrease in prolactin levels, and pharmacological intervention should be considered the first line therapy and involves the use of dopamine agonists to reduce tumour size and prolACTin levels.
Etiological diagnosis of hyperprolactinemia.
TLDR
There are numerous etiologies ofhyperprolactinemia, a common reason for consultation, and it is important to follow a rational diagnostic plan to rule out all non-tumoral causes of hyperprolactic causes before proceeding with imaging.
Pharmacological causes of hyperprolactinemia
TLDR
Hyperprolactinemia has also been documented during conditioning and after autologous blood stem-cell transplantation and during chemotherapy, even though disturbances of prolactin seem to occur less frequently than impairments of the hypothalamus-pituitary-gonad/thyroid axis after intensive treatment and blood marrow transplantation.
Medical treatment of prolactinomas
TLDR
Novel data indicate that these agents can be successfully withdrawn in a subset of patients after normalization of prolactin levels and tumor disappearance, which suggests the possibility that medical therapy may not be required throughout life.
Macroprolactinemia: Diagnostic, Clinical, and Pathogenic Significance
TLDR
Screening of macroprolactinemia is important for the differential diagnosis of hyperprolACTinemia to avoid unnecessary examinations and treatments.
Prolactin--not only lactotrophin. A "new" view of the "old" hormone.
TLDR
It is not surprising to learn that hyperprolactinaemia is a systemic condition which may predispose to numerous cardiovascular and immune-mediated reactions and the exact effects of PRL on both immune and cardiovascular systems are being currently unraveled.
Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland.
TLDR
It is postulate that PRL has a direct effect on adrenal steroidogenesis, thereby regulating adrenal function, which may be of particular relevance in clinical disorders with hyperprolactinemia.
Pituitary tumours: the prolactinoma.
  • A. Colao
  • Medicine
    Best practice & research. Clinical endocrinology & metabolism
  • 2009
TLDR
The patients achieving disappearance of the tumours and suppression of PRL levels during treatment are those showing the highest likelihood to have persistent remission of hyperprolactinaemia after treatment withdrawal.
Structural variants of prolactin: occurrence and physiological significance.
  • Y. Sinha
  • Biology, Medicine
    Endocrine reviews
  • 1995
TLDR
The purpose of this review is to provide an account of the recent advances in PRL, which suggests that the hormone is perhaps a prohormone, which is synthesized as a precursor molecule and then converted to different bioactive forms as it traverses the secretory pathway.
...
1
2
3
4
5
...